ArticleNigerian medical journal : journal of the Nigeria Medical Association
Prevalence of Iron Deficiency Anaemia among Chronic Heart Failure Patients in Owerri, Nigeria.
Article in Nigerian medical journal : journal of the Nigeria Medical Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Characteristics of Iron Deficiency in Patients with Chronic Heart Failure at a Major Referral Centre in Southern Nigeria.Nigerian medical journal : journal of the Nigeria Medical AssociationReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heart failure (HF) is defined as a clinical syndrome with symptoms and/or signs caused by a structural and/or functional cardiac abnormality and corroborated by elevated natriuretic peptide levels and/or objective evidence of pulmonary or systemic congestion. Iron deficiency (ID) and erythropoietin dysfunction have been demonstrated as the two basic mechanisms for anaemia in HF. Iron deficiency in chronic heart failure (CHF) is defined as serum ferritin < 100 μg/l or serum ferritin 100-299 μg/l +Transferrin saturation < 20%. In the presence of anaemia, ID is considered iron deficiency anaemia (IDA). This study aimed to evaluate the prevalence of IDA in patients with chronic heart failure. Methodology: This was a hospital-based, cross-sectional descriptive study carried out at Federal Teaching Hospital Owerri, Nigeria. One hundred and sixty (160) HF participants were consecutively recruited in this study. Iron deficiency anaemia was defined by serum ferritin level < 100ug/l or mean cell volume (MCV) < 80% and haemoglobin (Hb) < 10g/dl. The sociodemographic characteristics were obtained through a structured interviewer-administered questionnaire. Results: Ninety-five (59.4%) participants were males while 65 (40.6%) were females with a ratio of 1.5:1. The mean age of the total participant was 62.82±14.86 years. Of the 160 participants studied, 118 had anaemia with a prevalence of 73.8%. The prevalence of iron deficiency anaemia was 43.8%. Conclusion: The study demonstrated a high prevalence of iron deficiency anaemia among chronic heart failure patients in our environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.